Invited Faculty
  • Nathalie Costedoat-Chalumeau
    Cochin Hosp.
    France
  • Nathalie Costedoat-Chalumeau MD, PhD, is currently Professor of Medicine at Paris University and Senior Hospital practitioner at the Reference Center for Systemic and Autoimmune Diseases, Department of Medicine, Cochin Hospital in Paris. She trained in Internal Medicine, Immunology, Pharmacology and Rheumatology in Paris.
    Natalie’s research and practice has focused on systemic lupus erythematosus (SLE) and the antiphospholipid syndrome (APS) including its catastrophic variant and she has been involved on studies leading to landmark publications in hydroxychloroquine and its measurement in blood, adherence to treatment, and pregnancy in women with SLE and APS. She designed and successfully led several national and international longitudinal and cohort studies on SLE and APS: the PLUS study, the Adherence study, the GR2 study, and the neonatal lupus cohort. She is currently the principal investigator of the OBILUP study, an open label randomised multicentre controlled trial comparing oral corticosteroids plus mycophenolate mofetil versus Obinutuzumab and mycophenolate mofetil as induction therapy for lupus nephritis.
    She participated as a member of several international EULAR task forces: "Treat to target for SLE"; "Medication of rheumatic diseases in pregnancy"; "Women's health in SLE and APS"; "Remission in SLE"; “Antiphospholipid syndrome”. She was also a member of the international EULAR/ACR group that designed the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus. Finally, she is a member of the SLICC group.
    Pr. Costedoat-Chalumeau has published extensively including original papers in international journals; she is also a reviewer for national and international journal, and since 2013, member of the Editorial Board of the Lancet Rheumatology and Lupus Science and Medicine.
    Research & Clinical Focus

    antiphospholipid syndrome

    systemic lupus erythematosus

    pregnancy

    hydroxychloroquine

    • Date Time Room Session Title Lecture Title
    May 17 13:30-13:50 Room Grand Ballroom 102 [Study Group Session] The Systemic Lupus Erythematosus International Collaborating Clinics Group (SLICC) Study Group Session HCQ issue
    May 20 13:40-14:00 Room Grand Ballroom 102 [Concurrent Session 11] Antiphospholipid Syndrome Catastrophic antiphospholipid syndrome